Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS.
Protein A or G purified from hybridoma culture supernatant
Reconstitute at 0.5 mg/mL in sterile PBS.
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for FGF-BP Antibody (196519)
17 kDa heparin-binding growth factor-binding protein
FGFBPFGF-binding protein 1
fibroblast growth factor binding protein 1
fibroblast growth factor-binding protein 1
HBP1717 kDa HBGF-binding protein
heparin-binding growth factor binding protein
Fibroblast growth factor binding protein (FGF-BP), also known as HBp17, is a secreted glycoprotein that increases the bioavailability of FGFs (1). Mature FGF-BP is a 34 kDa, 211 amino acid (aa) O-glycosylated protein with five conserved intrachain disulfide bonds (2-4). FGF-BP contains a heparin-binding domain (aa 110-143) and a distinct FGF-binding region (aa 193-243) (5). Mature human FGF-BP shares 59% and 54% aa sequence identity with mouse and rat FGF-BP, respectively. FGF-BP is expressed throughout development and in adult squamous epithelium (2, 6). It is upregulated in injured skin, renal tubular epithelium, and spinal nerves as well as in carcinomas of the skin, colon, and pancreas (3, 7-10). FGF-BP binds FGF-1, -2, -7, -10, and -22 which are secreted and sequestered in the extracellular matrix (ECM) (7, 11). The association of FGF-BP with heparan sulfate proteoglycans (HSPG) weakens HSPG attachment of FGFs and promotes their release (2, 8, 12, 13). FGF-BP enhances the mitogenic effects of FGFs, thereby contributing to epithelial, endothelial, and neuronal tissue repair, angiogenesis, and tumor growth (7-9, 11, 14, 15).
Abuharbeid, S. et al. (2006) Int. J. Biochem. Cell Biol. 38:1463.
Wu, D. et al. (1991) J. Biol. Chem. 266:16778.
Tassi, E. et al. (2006) Cancer Res. 66:1191.
Lametsch, R. et al. (2000) J. Biol. Chem. 275:19469.
Xie, B. et al. (2006) J. Biol. Chem. 281:1137.
Aigner, A. et al. (2002) Histochem. Cell Biol. 117:1.
Beer, H-D. et al. (2005) Oncogene 24:5269.
Ray, P.E. et al. (2006) Am. J. Physiol. Regul. Integr. Comp. Physiol. 290:R105.
Tassi, E. et al. (2007) Am. J. Physiol. Regul. Integr. Comp. Physiol. 293:R775.
Kurtz, A. et al. (2004) Neoplasia 6:595.
Tassi, E. et al. (2001) J. Biol. Chem. 276:40247.
Mongiat, M. et al. (2001) J. Biol. Chem. 276:10263.
Kurtz, A. et al. (1997) Oncogene 14:2671.
Aigner, A. et al. (2001) Int. J. Cancer 92:510.
Czubayko, F. et al. (1997) Nat. Med. 3:1137.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
Review this Product
Be the first to review our FGF-BP Antibody (196519) and receive a gift card or discount.